Home › Free Stock Grades › MIRM
Mirum Pharmaceuticals, Inc. (MIRM) Stock Grade
MIRM · Healthcare
C
Market Cap
$5.4B
P/E Ratio
—
Revenue Growth (YoY)
+54.7%
Net Margin
-4.5%
Return on Equity
—
Dividend Yield
None
About Mirum Pharmaceuticals, Inc.'s fundamentals
Mirum Pharmaceuticals is a biotechnology company with a market capitalization of $5.4 billion that is experiencing rapid revenue growth of 54.7% year-over-year. While the company currently operates at a net loss with a negative margin of -4.5%, it maintains positive free cash flow despite its accounting losses, suggesting operational efficiency in cash generation. The company does not pay a dividend and has not yet achieved profitability on a net income basis.